These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 16216086)

  • 1. The geographic spread of the CCR5 Delta32 HIV-resistance allele.
    Novembre J; Galvani AP; Slatkin M
    PLoS Biol; 2005 Nov; 3(11):e339. PubMed ID: 16216086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The evolutionary history of the CCR5-Delta32 HIV-resistance mutation.
    Galvani AP; Novembre J
    Microbes Infect; 2005 Feb; 7(2):302-9. PubMed ID: 15715976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. More about the Viking hypothesis of origin of the delta32 mutation in the CCR5 gene conferring resistance to HIV-1 infection.
    Lucotte G; Dieterlen F
    Infect Genet Evol; 2003 Nov; 3(4):293-5. PubMed ID: 14636691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is the European spatial distribution of the HIV-1-resistant CCR5-Delta32 allele formed by a breakdown of the pathocenosis due to the historical Roman expansion?
    Faure E; Royer-Carenzi M
    Infect Genet Evol; 2008 Dec; 8(6):864-74. PubMed ID: 18790087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The case for selection at CCR5-Delta32.
    Sabeti PC; Walsh E; Schaffner SF; Varilly P; Fry B; Hutcheson HB; Cullen M; Mikkelsen TS; Roy J; Patterson N; Cooper R; Reich D; Altshuler D; O'Brien S; Lander ES
    PLoS Biol; 2005 Nov; 3(11):e378. PubMed ID: 16248677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of 32 alelle of the CCR5 gene in the population of Poland.
    Jagodzinski PP; Lecybył R; Ignacak M; Juszczyk J; Trzeciak WH
    J Hum Genet; 2000; 45(5):271-4. PubMed ID: 11043507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCR5-Delta32 allele frequencies in Ashkenazi Jews.
    Lucotte G; Smets P
    Genet Test; 2003; 7(4):333-7. PubMed ID: 15000812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of the HIV resistance CCR5-Delta32 allele among Egyptians and Syrians.
    Salem AH; Batzer MA
    Mutat Res; 2007 Mar; 616(1-2):175-80. PubMed ID: 17166523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CC chemokine receptor 5 Δ32 polymorphism: association analysis and allele distribution among cutaneous leishmaniasis patients from Pakistan.
    Sophie M; Hameed A; Muneer A; Samdani AJ; Saleem S; Azhar A
    J Cutan Pathol; 2016 Jul; 43(7):564-70. PubMed ID: 26970327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Could FIV zoonosis responsible of the breakdown of the pathocenosis which has reduced the European CCR5-Delta32 allele frequencies?
    Faure E
    Virol J; 2008 Oct; 5():119. PubMed ID: 18925940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is spatial distribution of the HIV-1-resistant CCR5Delta32 allele formed by ecological factors?
    Balanovsky O; Pocheshkhova E; Pshenichnov A; Solovieva D; Kuznetsova M; Voronko O; Churnosov M; Tegako O; Atramentova L; Lavryashina M; Evseeva I; Borinska S; Boldyreva M; Dubova N; Balanovska E
    J Physiol Anthropol Appl Human Sci; 2005 Jul; 24(4):375-82. PubMed ID: 16079584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of the CCR5 gene 32-basepair deletion in West Europe. A hypothesis about the possible dispersion of the mutation by the Vikings in historical times.
    Lucotte G
    Hum Immunol; 2001 Sep; 62(9):933-6. PubMed ID: 11543895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of the mutated delta 32 allele of the CCR5 gene in a Sicilian population.
    Sidoti A; D'Angelo R; Rinaldi C; De Luca G; Pino F; Salpietro C; Giunta DE; Saltalamacchia F; Amato A
    Int J Immunogenet; 2005 Jun; 32(3):193-8. PubMed ID: 15932625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of four HIV type 1-resistance polymorphisms (CCR5-Delta32, CCR5-m303, CCR2-64I, and SDF1-3'A) in the Bahraini population.
    Salem AH; Farid E; Fadel R; Abu-Hijleh M; Almawi W; Han K; Batzer MA
    AIDS Res Hum Retroviruses; 2009 Oct; 25(10):973-7. PubMed ID: 19803715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of the CCR5 gene 32-bp deletion in Europe.
    Lucotte G; Mercier G
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Oct; 19(2):174-7. PubMed ID: 9768627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of the CCR5-Delta32 HIV resistance gene in Bronze Age skeletons.
    Hummel S; Schmidt D; Kremeyer B; Herrmann B; Oppermann M
    Genes Immun; 2005 Jun; 6(4):371-4. PubMed ID: 15815693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequencies of gene variant CCR5-Δ32 in 87 countries based on next-generation sequencing of 1.3 million individuals sampled from 3 national DKMS donor centers.
    Solloch UV; Lang K; Lange V; Böhme I; Schmidt AH; Sauter J
    Hum Immunol; 2017 Nov; 78(11-12):710-717. PubMed ID: 28987960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 protecting CCR5-Delta32 allele in medieval Poland.
    Zawicki P; Witas HW
    Infect Genet Evol; 2008 Mar; 8(2):146-51. PubMed ID: 18162443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ancient DNA Investigation of a Medieval German Cemetery Confirms Long-Term Stability of CCR5-Δ32 Allele Frequencies in Central Europe.
    Bouwman A; Shved N; Akgül G; Rühli F; Warinner C
    Hum Biol; 2017 Apr; 89(2):119-124. PubMed ID: 29299966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of the CCR5 Delta32 mutation based on haplotype variation in Jewish and Northern European population samples.
    Klitz W; Brautbar C; Schito AM; Barcellos LF; Oksenberg JR
    Hum Immunol; 2001 May; 62(5):530-8. PubMed ID: 11334678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.